FDA Inspection 1167650 — The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C.
The FDA completed an inspection of The Center For Human Reproduction D.B.A. American Infertility Of New York, P.C. on Apr 11, 2022 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 11, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New York, NY (United States)